These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8393243)

  • 1. An immunodominant N-terminal region of VP1 protein of poliovirion that is buried in crystal structure can be exposed in solution.
    Roivainen M; Piirainen L; Rysä T; Närvänen A; Hovi T
    Virology; 1993 Aug; 195(2):762-5. PubMed ID: 8393243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic regions of poliovirus type 3/Sabin capsid proteins recognized by human sera in the peptide scanning technique.
    Roivainen M; Närvänen A; Korkolainen M; Huhtala ML; Hovi T
    Virology; 1991 Jan; 180(1):99-107. PubMed ID: 1701949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunodominant, cross-reactive B-cell epitope region is located at the C-terminal part of the hamster polyomavirus major capsid protein VP1.
    Siray H; Frömmel C; Voronkova T; Hahn S; Arnold W; Schneider-Mergener J; Scherneck S; Ulrich R
    Viral Immunol; 2000; 13(4):533-45. PubMed ID: 11192300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
    Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
    Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BC loop in poliovirus coat protein VP1: an ideal acceptor site for major insertions.
    Stirk HJ; Thornton JM
    Protein Eng; 1994 Jan; 7(1):47-56. PubMed ID: 7511245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of T-helper epitopes in the VP1 capsid protein of poliovirus.
    Kutubuddin M; Simons J; Chow M
    J Virol; 1992 May; 66(5):3042-7. PubMed ID: 1373200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric bacteriophage fr virus-like particles harboring the immunodominant C-terminal region of hamster polyomavirus VP1 induce a strong VP1-specific antibody response in rabbits and mice.
    Voronkova T; Grosch A; Kazaks A; Ose V; Skrastina D; Sasnauskas K; Jandrig B; Arnold W; Scherneck S; Pumpens P; Ulrich R
    Viral Immunol; 2002; 15(4):627-43. PubMed ID: 12513932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide antisera targeted to a conserved sequence in poliovirus capsid VP1 cross-react widely with members of the genus Enterovirus.
    Hovi T; Roivainen M
    J Clin Microbiol; 1993 May; 31(5):1083-7. PubMed ID: 8388885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of a predicted N-terminal amphipathic α-helix using atomistic molecular dynamics simulation of a complete prototype poliovirus virion.
    Roberts JA; Kuiper MJ; Thorley BR; Smooker PM; Hung A
    J Mol Graph Model; 2012 Sep; 38():165-73. PubMed ID: 23085162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
    Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
    Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction by synthetic peptides of broadly reactive, type-specific neutralizing antibody to poliovirus type 3.
    Ferguson M; Evans DM; Magrath DI; Minor PD; Almond JW; Schild GC
    Virology; 1985 Jun; 143(2):505-15. PubMed ID: 2414909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping of antigenic domains in poliovirus VP1 involved in structural rearrangements during virus morphogenesis and antigenic alterations of the virion.
    Ketterlinus R; Wiegers K
    Virology; 1994 Oct; 204(1):27-37. PubMed ID: 7522372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural comparison between retro-inverso and parent peptides: molecular basis for the biological activity of a retro-inverso analogue of the immunodominant fragment of VP1 coat protein from foot-and-mouth disease virus.
    Carver JA; Esposito G; Viglino P; Fogolari F; Guichard G; Briand JP; Van Regenmortel MH; Brown F; Mascagni P
    Biopolymers; 1997 Apr; 41(5):569-90. PubMed ID: 9095678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution.
    Basavappa R; Syed R; Flore O; Icenogle JP; Filman DJ; Hogle JM
    Protein Sci; 1994 Oct; 3(10):1651-69. PubMed ID: 7849583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.
    Li Q; Yafal AG; Lee YM; Hogle J; Chow M
    J Virol; 1994 Jun; 68(6):3965-70. PubMed ID: 7514682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
    Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification of immunodominant linear epitopes of dengue type 2 virus capsid and NS4a proteins using pin-bound peptides.
    Anandarao R; Swaminathan S; Khanna N
    Virus Res; 2005 Sep; 112(1-2):60-8. PubMed ID: 16022901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches.
    de Prat-Gay G
    Arch Biochem Biophys; 1997 May; 341(2):360-9. PubMed ID: 9169027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies.
    Chow M; Yabrov R; Bittle J; Hogle J; Baltimore D
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):910-4. PubMed ID: 2983321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding site of neutralizing monoclonal antibodies obtained after in vivo priming with purified VP1 of poliovirus type 1 is located between amino acid residues 93 and 104 of VP1.
    Wiegers KJ; Dernick R
    Virology; 1987 Mar; 157(1):248-51. PubMed ID: 2435056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.